Hytrin 1 Tablet contains Terazosin 1mg, an alpha-1 adrenergic receptor antagonist used primarily in the management of hypertension and benign prostatic hyperplasia (BPH). Terazosin works by selectively blocking alpha-1 receptors in vascular smooth muscle and the prostate, leading to vasodilation and relaxation of the bladder neck and prostate muscles. This dual action helps reduce blood pressure and improve urinary flow in patients with BPH. Hytrin 1 is indicated for patients requiring mild to moderate blood pressure control and those experiencing urinary symptoms associated with an enlarged prostate. The medication is administered orally, with dosage individualized based on patient response and tolerance, typically starting at a low dose to minimize the risk of orthostatic hypotension. Common side effects include dizziness, headache, fatigue, and nasal congestion, which are generally transient. Caution is advised in patients with a history of hypotension or those concurrently using other antihypertensive agents. Regular monitoring of blood pressure and symptom assessment is recommended to optimize therapeutic outcomes. Hytrin 1 Tablet should be used under medical supervision, with adherence to prescribed dosing to ensure safety and efficacy in managing hypertension and BPH-related symptoms.